Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Tam Anh Research Institute

ClinicalTrials.gov lists Tam Anh Research Institute as lead sponsor of 10 trials. It has 4 active development programs and 2 approved assets.

VN Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 19 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 4 Approved assets Approved assets 2 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 6 Organization relationships Organization relationships 1 Latest dated events Latest dated events 12 Disease areas Disease areas 19 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 4 Approved assets Approved assets 2 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 6 Organization relationships Organization relationships 1 Latest dated events Latest dated events 12

Rows recorded per section

1 more section with rows · 15 sections measured, none recorded

This page covers Tam Anh Research Institute: 10 lead-sponsored trials and 1 legal-entity registration.

Get the Tam Anh Research Institute report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (19)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Colorectal Neoplasms 3
Basal Ganglia Hemorrhage 1
Breast Neoplasms 1
Carcinoma, Hepatocellular 1
Cerebral Hemorrhage 1

Showing 5 of 19 disease areas.

Start your 14-day trial Email me all 19 disease areas as a PDF

Trials by start year as sponsor or collaborator (3)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 6
2025 3
2024 3

No forecast is made for this organization: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (4)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Dexmedetomidine + Desflurane Colorectal Neoplasms Not reported 1
Standard Medical Treatment Cerebral Hemorrhage Not reported 1
Standard Medical Treatment Hemorrhage Not reported 1
Standard Medical Treatment Basal Ganglia Hemorrhage Not reported 1

Approved assets (2)

Shown in this order: max phase first.

Approved assets
Drug Trials
PHENYLEPHRINE 1
Norepinephrine 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
1 of 1 hit target (n=1) 0 of 1 on time (n=1)

Journals published in (6)

Shown in this order: most published in first.

Journals published in
Journal Publications
Lancet (London, England) 4
The New England journal of medicine 2
EClinicalMedicine 1
European journal of gastroenterology & hepatology 1
Global epidemiology 1

Showing 5 of 6 journals.

Start your 14-day trial Email me all 6 journals as a PDF

Organization relationships (1)

Organization relationships
Related organization Relationship Evidence
Vietnam Vaccine Joint Stock Company Co sponsors trial with 1

Latest dated events (12)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-11-01 Planned start Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-16 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-03-19 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 12 events.

Start your 14-day trial Email me all 12 events as a PDF

Biomarker capability evidence (4)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ARIH1 Trial sponsor Named in trial inclusion criteria
ARIH1 Trial sponsor Named in trial inclusion criteria
ARIH1 Trial sponsor Mentioned in trial text
ARIH1 Trial sponsor Mentioned in trial text

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.